v3.26.3
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenues:        
Total revenues $ 357,807 $ 211,007 $ 990,877 $ 1,565,978
Operating expenses:        
Cost of product, collaboration and license sales, excluding amortization of acquired intangible assets 23,664 15,781 71,613 40,063
Amortization of acquired intangible assets 12,595 7,534 36,017 15,393
Research and development 105,353 100,158 305,376 322,121
Selling, general and administrative 80,081 84,046 246,894 250,269
Change in the fair value of contingent consideration       (800)
Tangible asset impairment and losses on transactions, net   472 927 648
Acquired in-process research and development 111,000   111,000  
Total operating expenses 332,693 207,991 771,827 627,694
Income from operations 25,114 3,016 219,050 938,284
Interest expense, net (45,866) (32,592) (143,377) (97,042)
Other (expense) income, net (1,073) 6,502 (2,415) (5,540)
Loss on extinguishment of debt (19,263)   (19,263)  
(Loss) income before income tax (expense) benefit (41,088) (23,074) 53,995 835,702
Income tax (expense) benefit (10,605) 38,970 (25,001) (18,093)
Net (loss) income attributable to common stockholders $ (51,693) $ 15,896 $ 28,994 $ 817,609
Weighted-average shares outstanding:        
Basic (in shares) 83,476,100 78,471,119 83,004,625 78,642,478
Diluted (in shares) 83,476,100 87,115,369 92,253,675 86,899,727
Net income(loss) per share        
Basic (in dollars per share) $ (0.62) $ 0.2 $ 0.35 $ 10.4
Diluted (in dollars per share) $ (0.62) $ 0.2 $ 0.34 $ 9.45
Net product revenue        
Revenues:        
Total revenues $ 275,894 $ 130,956 $ 740,286 $ 402,711
Collaboration and license revenue        
Revenues:        
Total revenues 229 9,258 50,967 998,430
Royalty revenue        
Revenues:        
Total revenues $ 81,684 $ 70,793 $ 199,624 $ 164,837